Share on:
So far in 2025, there have been 32 new drug approvals by the FDA. This means that novel treatment options are available for patients that may substantially improve public health. From drugs that treat metastatic breast cancer to drugs that treat moderate to severe pain, the new drugs introduced to the market will likely have a profound impact on a wide range of diseases. To be relevant practitioners, pharmacists and pharmacy technicians need to have a thorough understanding of the newly approved medications. The purpose of this knowledge-based activity is to educate pharmacists and pharmacy technicians on some of the recently approved drugs of 2025. More specifically, there will be information provided on the mechanism of action, effectiveness, safety, and handling of newly approved drugs.
Download the activity description to learn more.
Register - PHARMACISTS
